Immuneering (IMRX) Retained Earnings (2020 - 2026)

Immuneering's Retained Earnings history runs 7 years deep, the most recent figure standing at -$241005.0 for Q1 2026.

• In Q1 2026, Retained Earnings rose 99.9% year-over-year to -$241005.0; the TTM figure through Mar 2026 stood at -$241005.0 (up 99.9% YoY), while the FY2025 annual figure was $498.7 million, up 87.71% from the prior year.
• Retained Earnings for Q1 2026 stood at -$241005.0, down from $498.7 million in the prior quarter.
• The five-year high for Retained Earnings was $498.7 million in Q4 2025, with the low at -$268.7 million in Q3 2025.
• The 5-year median for Retained Earnings is -$83.7 million (2022), against an average of -$43.3 million.
• Peak annual rise in Retained Earnings reached 262.72% in 2024, while the deepest fall reached 35092275.3% in 2024.
• Immuneering's Retained Earnings stood at $219.6 million in 2022, then plunged by 174.33% to -$163.3 million in 2023, then surged by 262.72% to $265.7 million in 2024, then soared by 87.71% to $498.7 million in 2025, then slumped by 100.05% to -$241005.0 in 2026.
• Business Quant data shows IMRX's Retained Earnings at -$241005.0 in Q1 2026, $498.7 million in Q4 2025, and -$268.7 million in Q3 2025.